Zurich Cantonal Bank
CODX

Zurich Cantonal Bank’s Co-Diagnostics CODX Stock Holding History

Zurich Cantonal Bank’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-171
Closed -$49K – 2605
2021
Q1 		$49K Hold
171
– – ﹤0.01% 2393
2020
Q4 		$48K Hold
171
– – ﹤0.01% 2443
2020
Q3 		$70K Hold
171
– – ﹤0.01% 2138
2020
Q2 		$99K Buy
+171
New +$78.1K ﹤0.01% 1942

Other funds holding CODX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ARC
Advisor Resource Council Dallas, Texas $355M AUM 30.05% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Zurich Cantonal Bank's CODX Position: Q2 2021 in Review

Zurich Cantonal Bank sold out of Co-Diagnostics (CODX) in Q2 2021, closing a stake of 171 shares — an estimated $49K sold.

Zurich Cantonal Bank first reported a position in CODX in Q2 2020 and held it in 4 quarters. The position peaked at $99K in Q2 2020. 88 funds tracked by Wall St. Rank hold CODX as of Q2 2021.

  • Zurich Cantonal Bank reported no remaining Co-Diagnostics position as of Q2 2021 after selling out during the quarter.
  • Zurich Cantonal Bank sold 171 Co-Diagnostics shares in Q2 2021, an estimated $49K.
  • Zurich Cantonal Bank first reported a position in Co-Diagnostics in Q2 2020 and held it in 4 quarters.
  • Zurich Cantonal Bank's Co-Diagnostics position peaked at $99K in Q2 2020.
  • 88 funds tracked by Wall St. Rank held Co-Diagnostics as of Q2 2021.

Based on Zurich Cantonal Bank's 13F filing for Q2 2021, filed 30 Jul 2021.